Skip to main content

Table 1 Characteristics of study subjects by number of participants and prevalence of falls during survey years

From: Prevalence and risk factors of falls among community-dwelling older people: results from three consecutive waves of the national health interview survey in Taiwan

Characteristics

2005

2009

2013

No. of participants

Prevalence of falls and p-value

No. of participants

Prevalence of falls and p-value

No. of participants

Prevalence of falls and p-value

N = 2722

%

n

%

N = 2900

%

n

%

N = 3200

%

n

%

Total

2722

100.0

579

21.3

2900

100.0

565

17.5

3200

100.0

528

16.5

Mean age (±SD, year)

75.1

±6.0

  

75.6

±6.3

  

76.4

±6.5

  

Age

   

0.002

   

0.017

   

0.004

 65–69

868

31.9

147

16.9

877

30.2

131

14.0

852

26.6

110

12.1

 70–74

743

27.3

161

20.9

726

25.0

141

18.5

866

27.1

135

16.2

 75–79

619

22.7

141

23.2

653

22.5

131

16.4

654

20.4

115

17.9

 80–84

329

12.1

88

28.1

388

13.4

96

23.0

503

15.7

99

18.7

 85+

163

6.0

42

26.1

256

8.8

66

21.3

325

10.2

69

24.3

Sex

   

< 0.001

   

< 0.001

   

0.224

 Male

1346

49.4

221

16.5

1252

43.2

198

14.1

1523

47.6

227

15.3

 Female

1376

50.6

358

26.2

1648

56.8

367

20.6

1677

52.4

301

17.5

ADL difficulty

   

< 0.001

   

< 0.001

   

< 0.001

 None

2324

85.4

419

18.1

2382

82.2

399

15.2

2658

83.1

379

13.8

 1 task

74

2.7

33

45.9

109

3.8

33

29.0

112

3.5

38

44.5

  ≥ 2 tasks

322

11.8

127

39.4

406

14.0

133

28.4

427

13.4

111

27.2

IADL difficulty

   

< 0.001

   

< 0.001

   

< 0.001

 None

1574

58.1

232

15.0

2275

79.4

371

14.8

1943

61.5

244

11.9

 1 task

361

13.3

67

19.0

105

3.7

28

25.1

349

11.0

57

16.0

  ≥ 2 tasks

775

28.6

278

35.7

486

17.0

161

29.1

868

27.5

216

27.5

Use of sleeping pills use

   

0.005

   

0.022

   

0.009

 No

2422

89.1

496

20.4

2521

87.4

468

16.7

2715

85.1

422

15.4

 Yes

297

10.9

83

28.6

363

12.6

94

22.9

477

14.9

106

22.3

Vision

   

< 0.001

   

0.002

   

< 0.001

 Clear

772

32.1

129

17.4

815

32.0

109

12.8

974

34.2

109

11.1

 Average

1020

42.4

184

17.7

1097

43.1

206

17.0

1296

45.5

189

14.3

 Unclear

615

25.6

166

28.1

635

24.9

159

22.2

579

20.3

146

27.7

Frequency of exercise

   

0.018

   

0.001

   

< 0.001

 None

1246

45.8

298

24.2

1370

50.0

311

21.2

1524

50.4

301

20.3

 Irregular

167

6.1

34

19.3

138

5.0

17

13.0

107

3.5

20

13.4

 Regular

1306

48.0

247

19.1

1233

45.0

196

13.8

1394

46.1

170

12.6

Comorbidities

   

< 0.001

   

0.051

   

0.022

 0

879

38.5

116

12.2

942

33.5

153

14.2

884

28.6

104

12.4

 1

690

30.2

131

19.2

957

34.0

185

17.6

995

32.2

175

16.4

  ≥ 2

712

31.2

187

28.5

916

32.5

202

19.6

1207

39.1

218

18.5

Urinary incontinence

   

< 0.001

   

0.002

   

< 0.001

 No

2066

76.1

384

18.8

2603

90.2

485

16.5

2544

79.9

367

14.0

 Yes

649

23.9

194

29.6

284

9.8

77

26.0

640

20.1

156

25.5

Depressive symptoms

   

< 0.001

   

< 0.001

   

< 0.001

 No

1715

71.4

282

16.3

1999

76.4

297

13.6

2229

79.6

282

12.5

 Yes

686

28.6

198

30.0

617

23.6

193

27.7

570

20.4

139

24.9

  1. Note: p-value < 0.05 using the chi-square test indicates a statistically significant fall risk across each explanatory variable. The prevalence of falls was estimated by weighing according to sampling probability proportional to the population size. SD standard deviation